General Methods for Chemistry. All air or moisture sensitive reactions were performed under positive pressure of nitrogen with oven-dried glassware. Anhydrous solvents such as dichloromethane, N,N-dimethylforamide (DMF), acetonitrile, dioxan, dimethoxyethane, methanol and triethylamine were purchased from Sigma-Aldrich. Tetrakis and a 50 % of solution of propylphosphonic anhydride (T3P®) in DMF or ethyl acetate were purchased from Strem chemicals and used used as such. SiliaCat® Heterogeneous Catalyst DPP-Pd (Catalog # R390-100) was purchased from SiliCycle Inc. Preparative purification was performed on a Waters semi-preparative HPLC system using a Phenomenex Luna C18 column (5 micron, 30 x 75 mm) at a flow rate of 45 mL/min. The mobile phase consisted of acetonitrile and water (each containing 0.1% trifluoroacetic acid). A gradient of 10% to 50% acetonitrile over 8 minutes was S3 used during the purification. Fraction collection was triggered by UV detection (220 nm). Analytical analysis was performed on an Agilent LC/MS (Agilent Technologies, Santa Clara, CA). Method 1: A 7 minute gradient of 4% to 100% Acetonitrile (containing 0.025% trifluoroacetic acid) in water (containing 0.05% trifluoroacetic acid) was used with an 8 minute run time at a flow rate of 1 mL/min. A Phenomenex Luna C18 column (3 micron, 3 x 75 mm) was used at a temperature of 50° C. Method 2: A 3 minute gradient of 4% to 100% Acetonitrile (containing 0.025% trifluoroacetic acid) in water (containing 0.05% trifluoroacetic acid) was used with a 4.5 minute run time at a flow rate of 1 mL/min. A Phenomenex Gemini Phenyl column (3 micron, 3 x 100 mm) was used at a temperature of 50° C. Method 3: Analysis was performed on an Agilent 1290 Infinity Series HPLC. UHPLC Long Gradient Equivalent 4% to 100% acetonitrile (0.05% trifluoroacetic acid) in water over 3.5 minutes run time of 4 minutes with a flow rate of 0.8 mL/min. A Phenomenex Kinetex 1.7 micron C18 column (2.1 x 100 mm) was used at a temperature of 50 °C. Purity determination was performed using an Agilent Diode Array Detector for both Method 1, Method 2 and Method 3. Mass determination was performed using an Agilent 6130 mass spectrometer with electrospray ionization in the positive mode.
1 H NMR spectra were recorded on Varian 400 MHz spectrometers. Chemical shifts are reported in ppm with undeuterated solvent (DMSO-d 6 at 2.49 ppm) as internal standard for DMSO-d 6 solutions. All of the analogs tested in the biological assays have purity greater than 95%, based on both analytical methods. High resolution mass spectrometry was recorded on Agilent 6210 Time-of-Flight LC/MS system. Confirmation of molecular formula was accomplished using electrospray ionization in the positive mode with the Agilent Masshunter software (version B.02). 09 -8.00 (m, 2H), 7.99 -7.89 (m, 2H), 7.63 -7.56 (m, 2H), 3.07 -3.02 (m, 3H) 
5-(Methylamino

General Procedure C: Synthesis of compounds 20-26 and 28-31:
A suspension of copper(II) chloride (13.10 g, 97 mmol, 2.05 eq.) in acetonitrile (200 mL) was added t-butyl nitrite (13.82 mL, 105 mmol, 2.2 eq.) followed by 5-amino-2-(naphthalen-1-yl)oxazole-4-carbonitrile (11.18 g, 47.5 mmol, 1 eq.) in portions at room temperature. The reaction mixture was stirred for 3 h then concentrated and extracted with ethyl acetate. The organic layer was successively washed with 1% HCl, water and brine. The organic layer was dried over MgSO 4 , filtered and concentrated under diminished pressure. The crude product was purified on a biotage® flash system eluting with 40% CH 2 Cl 2 in hexanes to furnish 4.2 g (Yield: 35%) of 5-chloro-2-(naphthalen-1-yl)oxazole-4-carbonitrile (19a) as white solid.
1 H NMR (400 MHz, DMSO-d 6 ) δ 8.99 (dq, J = 8.6, 0.9 Hz, 1H), 2H), 8.09 (ddt, J = 8.1, 1.3, 0.6 Hz, 1H), 3H) . A mixture of 5-chloro-2-(naphthalen-1-yl)oxazole-4-carbonitrile (19a) (0.25 mmol, 1 eq.) and appropriate amine (10 eq) in THF was heated to reflux for 0.5 h. The reaction mixture was then cooled and the solvent was removed by forced air. The crude product was taken up in DMSO and purified via reversed phase preparative HPLC to obtain pure products as TFA salts. 
5-(Ethylamino)-2-(naphthalen-1-yl)oxazole-4-carbonitrile TFA (21). LC-MS Retention
N-methyl-5-(naphthalen-1-yl)oxazol-2-amine (33)
A solution of 5-(naphthalen-1-yl)oxazole 33a (0.5 g, 2.56 mmol, 1 eq.) in THF (15 mL) was added a 1 M THF solution of LHMDS (2.82 mL, 2.82 mmol, 1.1 eq.) dropwise at -78 o C. The reaction mixture was stirred for 30 minutes at -78 o C then perchloroethane (0.667 g, 2.82 mmol, 1.1 eq.) was added in one portion and allowed to reach room temperature over 4 h. The reaction mixture was quenched with saturated ammonium chloride and extracted with ethyl acetate. The organic layer was washed with water and brine then dried over magnesium sulfate, filtered and concentrated under diminished pressure. The crude product was purified on a Biotage® flash S8 system eluting with 10% ethyl acetate in hexanes to furnish 0.54 g (Yield: 92 %) of 2-chloro-5-(naphthalen-1-yl)oxazole 33b as white solid. A solution of 2-chloro-5-(naphthalen-1-yl)oxazole 33b (0.1 g, 0.435 mmol, 1 eq.) in THF (1 mL) was added a 2 M solution of methanamine in THF (1.09 mL, 2.18 mmol, 5 eq.) and stirred at 65 o C for 1 h in a sealed tube. The solvent was removed by forced air to obtain a crude solid. This crude product was taken up in DMSO and purified on a preparative HPLC to obtain N-methyl-5-(naphthalen-1-yl)oxazol-2-amine (33) 
N-methyl-5-(naphthalen-1-yl)-1,3,4-oxadiazol-2-amine (35).
A mixture of 1-naphthoic acid (0.2 g, 1.16 mmol, 1 eq.), N-methylhydrazinecarbothioamide (0.122 g, 1.16 mmol, 1 eq.) and EDC (0.668 g, 3.48 mmol, 3 eq.) in DMF (3 mL) was stirred at room temperature for 12 h. The reaction mixture was filtered and purified on a HPLC. LC-MS Retention Time: (Method 3) = 1.905 min and (Method 2) = 3.048 min; 1 H NMR (400 MHz, DMSO-d 6 ) δ 9.11 (ddq, J = 8.7, 1.5, 0.7 Hz, 1H), 8.14 -7.93 (m, 3H), 7.78 -7.50 (m, 4H), 2.92 (dd, J = 4.9, 0.6 Hz, 3H); HRMS (ESI) m/z (M+H) + calcd. for C 13 H 12 N 3 O, 226.0975; found 226.0976.
N-methyl-5-(naphthalen-1-yl)-1,3,4-thiadiazol-2-amine (36).
A solution of 1-naphthoic acid (0.1 g, 0.581 mmol, 1 eq.), N-methylhydrazinecarbothioamide (0.061 g, 0.581 mmol, 1 eq.) in DMF (1 mL) was added triethylamine (0.24 mL, 1.74 mmol, 3 eq.) followed by a 50% solution of propylphosphonic anhydride (T 3 P) (0.92 g, 1.45 mmol, 2.5 eq.) dropwise. The reaction mixture was stirred at room temperature for 6 h then filtered through a celite plug. 
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Methyl 5-(methylamino)-2-(naphthalen-1-yl)oxazole-4-carboxylate (37). A suspension of 5-methoxy-2-(naphthalen-1-yl)oxazole-4-carboxylic acid 37a (3.6 g, 13.37 mmol, 1 eq.) in dichloromethane (50 mL) was added few drops of DMF and cooled in an ice bath. To the cold suspension was added oxalyl chloride (1.8 mL, 20.06 mmol, 1.5 eq.) dropwise. The reaction mixture was stirred at room temperature for 2 h. Excess solvent was evaporated under diminished pressure and the product was dried under vacuum. The crude solid was re-dissolved in dichloromethane (25 mL) and a 2 M solution of methanamine in THF (8 mL, 16.04 mmol) was added followed by triethyl amine (2.80 mL, 20.06 mmol) upon cooling. The reaction mixture was stirred at room temperature for 1 h then concentrated and purified on a Biotage® flash system eluting with 50% ethyl acetate in hexanes to furnish 2.2 g (Yield: 58 %) of 5-methoxy-N-methyl-2-(naphthalen-1-yl)oxazole-4-carboxamide (37b) 
Methyl 5-(methylamino)-2-(naphthalen-1-yl)thiazole-4-carboxylate (38).
To a suspension of methyl 2-bromo-5-(methylamino)thiazole-4-carboxylate (1.55 g, 6.17 mmol, 1 eq.), naphthalen-1-ylboronic acid (2.12 g, 12.35 mmol, 2 eq.), SiliaCat-DPP-Pd (2.0 g, 0.309 mmol, 5 mol%) (purchased from silicycle, catalog # R390-100) in dimethoxyethane (30 mL) was added a 2 M solution of sodium carbonate in water (9.3 mL, 18.52 mmol, 3 eq.). The reaction mixture was bubbled with argon for 5 minutes and then stirred at 105 o C for 24 h. The reaction mixture was concentrated and taken up in dichloromethane and stirred with palladium scavenger resin. After filtering through celite and removal of the solvent, a portion of the crude product was purified on HPLC. LC-MS Retention Time: 6-(naphthalen-1-yl) nicotinonitrile (39). A mixture of 2,6-dichloronicotinonitrile (0.500 g, 2.89 mmol, 1 eq.), naphthalen-1-ylboronic acid (0.522 g, 3.03 mmol, 1.05 eq.) and a solution of sodium carbonate in 3 mL of water (0.680 g, 8.09 mmol, 2.8 eq.) in dioxane (12 mL) was bubbled with argon for 5 minutes. Pd(PPh 3 ) 4 (0.167 g, 0.145 mmol, 5 mol %) was then added and heated to reflux under nitrogen for 3 h. The reaction mixture was then stirred with palladium scavenger resin and filtered through celite. The filtrate was concentrated and purified on a Biotage® flash system eluting with 20% ethyl acetate in hexanes to give 0.45 g (Yield: 59 %) of 39a. The above 2-chloro-6-(naphthalen-1-yl)nicotinonitrile (0.12 g, 0.453 mmol) (39a) and a 2 M THF solution of methanamine (1.13 ml, 2.27 mmol) in 2-iPrOH (1 mL) was heated in a MW for 30 min at 120 o C. The crude product obtained upon concentration was taken up in DMSO and purified via reversed phase HPLC to obtain pure 39 as a TFA salt. LC-MS Retention Time: (Method 3) = 1.803 min and (Method 2) = 3.796 min; 1 H NMR (400 MHz, DMSO-d 6 ) δ 8. 26 -8.17 (m, 1H), 8.15 -7.92 (m, 3H), 7.76 -7.48 (m, 4H) 8.25 (m, 1H), 8.04 (ddd, J = 15.4, 7.7, 2.2 Hz, 2H), 4H) 
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HT22 Cell Culture Assay. Glutathione depletion was induced in HT22 cells by glutamate treatment, and LDH release into the medium was measured to detect cell death as described. 38 Briefly, HT22 cells were cultured in DMEM containing 10% fetal bovine serum and penicillin / streptomycin (all media from Invitrogen). For viability experiments, cells were seeded at 1 x 10 4 cells/well in 96-well plates (Corning) and treated 18h later, when the cells were approximately 50-70% confluent. Treatment consisted of exchanging the medium to 100 µl fresh culturing medium and adding 5 mM glutamate (stock solution 0.5 M in PBS) in the presence or absence of DMSO (maximum 0.1% final concentration) as control or the indicated concentrations of 1. Lactate dehydrogenase (LDH) content was determined separately for the cell extracts and corresponding media using a Cytotoxicity Detection Kit (Roche), and the percentage of LDH released to the medium calculated after subtracting the corresponding background value. To determine levels of the 12/15-LOX metabolite, 12-HETE, we cultured HT22 cells in 75 cm 2 flasks in DMEM medium without phenol red, supplemented with 5% FBS, and treated the cells the next day when cells were 50-70% confluent. 24 hours later, the eicosanoid-containing fraction was isolated via Sep-Pak C-18 column, and 12-HETE was detected with a 12-HETE ELISA kit (Enzo Life Sciences, used according to the manufacturer's instruction). Three independent experiments were evaluated. For the MS samples, the above procedure was modified slightly. The eicosanoids containing fractions were transferred to scintillation vials followed by addition of perdeuterated 13-HODE (13-d 31 -HODE), as an internal control for extraction and 1.5% glacial acetic acid for protein precipitation. The samples were extracted with methylene chloride, reduced with trimethylphosphite and evaporated to dryness. The dry samples were then re-constituted in methanol and an internal control 12-deuterated (d 8 )-HETE (12-d 8 -HETE), was added to each sample for detector response variation and it was assumed that the change in detector response for 12-HETE and 12-d 8 -HETE would be similar. The samples were run on and analyzed by Finnigan LTQ liquid chromatography−tandem mass spectrometry (LC−MS/MS) system. A Thermo Electron Corp. Aquasil (3 µm, 100 mm × 2.1 mm) C-18 column was used to detect the HETEs with an elution protocol consisting of 0.2 mL /min flow rate and a linear gradient from 54.9% ACN, 45% H 2 O, and 0.1% THF to 69.9% ACN, 30% H 2 O, and 0.1% THF. The electrospray voltage was set to 5.0 kV and a global acquisition MS mode was used. The MS-MS scan was performed for the five most abundant precursor ions. The Collision Induced Dissociation (CID) was used for MS-MS with collision energy of 35 eV. The corresponding 12-HETE, 12-d 8 -HETE and 13-d 31 -HODE compounds were detected using selective ion monitoring analysis (m/z =318.7 to 319.7, 326.8 to 327.7 and 325.8 to 326.8 respectively) in negative ion mode and then identified by fragmentation pattern (12-HETE, parent ion at m/z 319 and fragments at m/z 179 and 163; 12-d 8 -HETE, parent ion at m/z 327 and fragments at m/z 184 and 13-d 31 -HODE, parent ion m/z 326 and fragments at m/z 213) from MS-MS. The peak area of 12-d 8 -HETE for each sample was normalized to the area of 13-d 31 -HODE. The peak intensities of 12-HETEs were normalized to the corrected 12-d 8 -HETE intensities. The amount of 12-HETE in samples was estimated from the pure 12-(S)-HETE standard curve. b UV-vis pseudoperoxidase activity assay was performed (section 2.1.6) on all the four selected analogs and no degradation of the hydroperoxide product was observed at 234 nm, indicating a nonreductive inhibitory mechanism. 
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